Royalty Pharma (RPRX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Royalty Pharma

    NASDAQ: RPRX · Real-Time Price · USD
    36.07
    -0.42 (-1.15%)
    At close: Oct 03, 2025, 3:59 PM
    36.00
    -0.19%
    After-hours: Oct 03, 2025, 06:22 PM EDT

    Royalty Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 578.66M 568.25M 593.64M 564.69M 537.27M 567.98M 596.07M 536.31M 538.2M 683.97M 565.75M 573.46M 535.96M 562.05M 575.7M 585.77M 554.96M 573.03M
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 578.66M 568.25M 593.64M 564.69M 537.27M 567.98M 596.07M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Income
    		 209.8M 534.18M 361.51M 735.07M 269.63M -73.77M 612.9M 151.44M 248.84M 478.97M -482.65M 192.21M 377.79M 219.72M 153.42M 303.05M 744.95M 229.3M
    Interest Income
    		 8.33M 11.29M 9.04M 17.51M 13.38M 7.42M 6.5M 23.44M 25.65M 16.7M 43.85M 14.03M 10.92M 9.53M 10.64M 12.26M 14.04M 16.6M
    Pretax Income
    		 90.64M 433.43M 334.35M 806.36M 194.38M -4.27M 717.59M 122.08M 351.34M 509.09M -610.03M 220.41M 491.6M 128.08M 53.67M 221.8M 806.75M 158.98M
    Net Income
    		 30.18M 238.35M 208.21M 543.99M 102M 4.78M 494.34M 72.11M 227.63M 340.75M -456.08M 142.65M 304.5M 51.76M 7.9M 101.93M 440.78M 69.12M
    Selling & General & Admin
    		 179.77M 110.7M 67.59M 56.72M 54.71M 57.65M 59.19M 57.23M 47.63M 85.69M 73.23M 50.69M 51.84M 51.54M 46.16M 48.59M 44.92M 43.16M
    Research & Development
    		 300.5M 50.5M 500K 500K 500K 500K 500K 50.5M 500K 500K 50.5M 25.5M 606K 100.5M 103.82M 90.5M 3.12M 2.64M
    Other Expenses
    		 -111.4M -127.14M 164.04M -227.6M 212.43M 583.6M -76.51M 277.14M 241.23M 118.8M 924.67M 305.06M 105.71M 190.29M 272.3M 143.63M -238.03M 297.93M
    Operating Expenses
    		 368.87M 34.06M 232.13M -170.38M 267.64M 641.75M -16.83M 384.87M 289.36M 205M 1.05B 381.25M 158.16M 342.33M 422.28M 282.72M -189.99M 343.73M
    Interest Expense
    		 68.67M 65.26M 65.76M 66.51M 49.01M 44.23M 47.26M 46.03M 46.95M 46.95M 46.95M 46.98M 46.97M 47.06M 46.97M 44.33M 37.43M 37.41M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a -185K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 368.87M 34.06M 232.13M -170.38M 267.64M 641.75M -16.83M 384.87M 289.36M 205M 1.05B 381.25M 158.16M 342.33M 422.28M 282.72M -189.99M 343.73M
    Income Tax Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 432.29M 425.59M 445.99M 446.04M 451.02M 448.62M 446.57M 448.44M 450.4M 445.61M n/a 439.29M 436.32M 433.96M n/a 428.23M 409.34M 389.76M
    Shares Outstanding (Diluted)
    		 562M 578M 589M 593M 596.91M 597.48M 446.57M 601.14M 605.86M 607.25M n/a 607.23M 607.21M 607.2M n/a 607.17M 607.16M 607.15M
    EPS (Basic)
    		 0.07 0.56 0.47 1.22 0.23 0.01 1.11 0.16 0.51 0.76 n/a 0.32 0.70 0.12 n/a 0.24 1.08 0.18
    EPS (Diluted)
    		 0.05 0.41 0.35 0.92 0.23 0.01 1.11 0.16 0.50 0.76 n/a 0.32 0.70 0.12 n/a 0.24 1.08 0.18
    EBITDA
    		 159.3M 498.69M 400.11M 872.86M 243.39M 39.96M 764.84M 168.11M 398.29M 556.04M -563.08M 267.39M 538.56M 180.82M 106.44M 271.92M 849.91M 202.06M
    EBIT
    		 159.3M 498.69M 400.11M 872.86M 243.39M 39.96M 764.84M 168.11M 398.29M 556.04M -563.08M 267.39M 538.56M 175.15M 100.64M 266.12M 844.18M 196.39M
    Depreciation & Amortization
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 5.67M 5.8M 5.8M 5.73M 5.67M

    Add to Watchlist